Select for export Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.647909 PubMed 34267683 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-06-28 Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. Europe PMC Published psilocybin WellbeingSpiritualityObservational Study Observational Study More
Select for export Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.687546 PubMed 34220590 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-06-15 Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC Europe PMC Published psilocybin Personality ChangeSpiritualityObservational Study Observational Study More
Select for export Psilocybin: From Serendipity to Credibility? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.659044 PubMed 33967860 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-04-20 Rucker JJ, Young AH. Europe PMC Published psilocybin AgingClinical TrialSafety Clinical Trial More
Select for export Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.586682 PubMed 33643087 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-02-02 Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00896 PubMed 32116806 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-02-10 James Sexton, Charles D. Nichols, Peter S. Hendricks OpenAlex Published psilocybin PharmacologyObservational StudySafety Observational Study More
Select for export Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00955 PubMed 32038317 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-01-21 Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson OpenAlex Published psilocybin AddictionChronic PainReceptor Pharmacology Observational Study More
Select for export Psilocybin and Mental Health-Don't Lose Control. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyt.2018.00293 PubMed 30018574 Copy citation Copy BibTeX Frontiers in Psychiatry 2018-07-02 Barnby JM, Mehta MA. Europe PMC Published psilocybin General Other More
